XSHE002001
Market cap9.26bUSD
Dec 24, Last price
22.24CNY
1D
1.23%
1Q
14.23%
Jan 2017
92.89%
Name
Zhejiang Nhu Co Ltd
Chart & Performance
Profile
Zhejiang NHU Company Ltd. engages in the production and sale of nutritional products, flavor and fragrances, new polymer materials, and APIs in China. The company offers nutrition products, such as vitamin E, vitamin A, vitamin C, DL-Methionine, vitamin D3, biotin, coenzyme Q10, carotenoids, etc. for used in feed additives, and nutrition supplements of food, beverages, health food, etc.; and flavor and fragrance products comprising linalool series, citral series, cis-3-hexenol series, methyl dihydrojasmonate, raspberry ketone, and ligustral for used in personal care, cosmetic, and food fields. It also provides polymer materials, including polyphenylene sulfide and poly phthalamide for used in electronic and electrical, automotive, environmental protection, etc.; and APIs, such as moxifloxacin hydrochloride, vitamin A, vitamin D3, etc. to use as active pharmaceutical ingredients for processing and producing pharmaceutical preparations. The company was incorporated in 1999 and is based in Xinchang, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | ||||||||||
Revenues | 15,116,537 -5.13% | 15,933,984 7.68% | 14,797,989 43.47% | |||||||
Cost of revenue | 11,557,815 | 11,172,251 | 9,226,224 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 3,558,722 | 4,761,733 | 5,571,765 | |||||||
NOPBT Margin | 23.54% | 29.88% | 37.65% | |||||||
Operating Taxes | 528,126 | 599,835 | 690,514 | |||||||
Tax Rate | 14.84% | 12.60% | 12.39% | |||||||
NOPAT | 3,030,597 | 4,161,898 | 4,881,251 | |||||||
Net income | 2,704,239 -25.30% | 3,620,281 -16.89% | 4,356,011 22.23% | |||||||
Dividends | (1,833,427) | (1,793,794) | (1,504,064) | |||||||
Dividend yield | 3.48% | 3.11% | 1.57% | |||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
Debt | ||||||||||
Debt current | 2,798,418 | 4,438,061 | 3,432,832 | |||||||
Long-term debt | 6,832,123 | 5,279,282 | 5,154,686 | |||||||
Deferred revenue | 1,083,159 | 1,063,700 | ||||||||
Other long-term liabilities | 1,065,586 | 1 | 1 | |||||||
Net debt | 4,193,981 | 3,653,177 | 1,383,872 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 5,119,371 | 4,361,481 | 5,837,878 | |||||||
CAPEX | (4,445,522) | |||||||||
Cash from investing activities | (3,877,686) | |||||||||
Cash from financing activities | (2,035,825) | |||||||||
FCF | 1,027,223 | 1,977 | 3,152,076 | |||||||
Balance | ||||||||||
Cash | 4,716,417 | 6,064,167 | 7,203,646 | |||||||
Long term investments | 720,143 | |||||||||
Excess cash | 4,680,734 | 5,267,467 | 6,463,747 | |||||||
Stockholders' equity | 22,084,775 | 20,827,216 | 18,336,564 | |||||||
Invested Capital | 30,929,862 | 28,984,163 | 24,627,499 | |||||||
ROIC | 10.12% | 15.53% | 20.71% | |||||||
ROCE | 9.93% | 13.79% | 17.84% | |||||||
EV | ||||||||||
Common stock shares outstanding | 3,108,320 | 3,073,422 | 3,080,887 | |||||||
Price | 16.96 -9.55% | 18.75 -39.75% | 31.12 10.87% | |||||||
Market cap | 52,717,114 -8.52% | 57,626,656 -39.90% | 95,877,216 10.39% | |||||||
EV | 57,026,142 | 61,367,123 | 97,324,819 | |||||||
EBITDA | 5,262,610 | 6,151,901 | 6,793,939 | |||||||
EV/EBITDA | 10.84 | 9.98 | 14.33 | |||||||
Interest | 319,906 | 329,244 | 337,753 | |||||||
Interest/NOPBT | 8.99% | 6.91% | 6.06% |